Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02686476
What this trial is testing

Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes

Who this might be right for
Non Alcoholic Fatty Liver Disease
Medanta, The Medicity, India 100
Not applicableLooking for participantsNCT03875625
What this trial is testing

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity, MorbidBrown Fat+4 more
Chinese University of Hong Kong 80
Not applicableActive Not RecruitingNCT05275608
What this trial is testing

Effects of VLCKD in Metabolic Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseObesity+1 more
Azienda Ospedaliero Universitaria Maggiore della Carita 40
Early research (Phase 1)Ended earlyNCT04565717
What this trial is testing

ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic SteatohepatitisNASH
Alnylam Pharmaceuticals 6
Not applicableUnknownNCT06032650
What this trial is testing

Calisthenics Versus High Intensity Interval Training in NAFL

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Cairo University 60
Not applicableStudy completedNCT05052515
What this trial is testing

The Effects of Dihydromiricetin on MASLD

Who this might be right for
NAFLD
University of Athens 55
Testing effectiveness (Phase 2)Study completedNCT06127225
What this trial is testing

Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease (NAFLD)
Dexa Medica Group 80
Not applicableStudy completedNCT02520609
What this trial is testing

Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Liver DiseaseFatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 53
Not applicableNot Yet RecruitingNCT07793279
What this trial is testing

Hypothyroidism and Liver Fibrosis Severity in MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHypothyroidismLiver Cirrhosis+1 more
Assiut University 85
Not applicableStudy completedNCT03664596
What this trial is testing

Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan 80
Testing effectiveness (Phase 2)Ended earlyNCT04147195
What this trial is testing

Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT05795517
What this trial is testing

Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）

Who this might be right for
Hypercholesterolemia
Haisco Pharmaceutical Group Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT00794716
What this trial is testing

PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Norgine 125
Post-approval studies (Phase 4)Ended earlyNCT01406704
What this trial is testing

Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH

Who this might be right for
NASH (Non-alcoholic Steato-hepatitis)
Seoul St. Mary's Hospital 26
Testing effectiveness (Phase 2)Ended earlyNCT03511365
What this trial is testing

Effects of Probiotic on Inflammation and Microbiota in Patients With NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseProbiotics MeSH Descriptor Data 2018Interleukin-17 MeSH Descriptor Data 2018
Northwell Health 6
Testing effectiveness (Phase 2)Study completedNCT04166773
What this trial is testing

Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Eli Lilly and Company 190
Testing effectiveness (Phase 2)Study completedNCT06256926
What this trial is testing

A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver Without Mention of Alcohol
COD Research Private Ltd 30
Not applicableNot Yet RecruitingNCT07285135
What this trial is testing

Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver Disease
Singapore General Hospital 60
Not applicableStudy completedNCT01657773
What this trial is testing

Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm

Who this might be right for
Colorectal NeoplasmsNonalcoholic Fatty Liver Disease
Wenzhou Medical University 2,315
Not applicableNot Yet RecruitingNCT06749704
What this trial is testing

Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver Disease
Institute of Liver and Biliary Sciences, India 140
Next Page